This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Catlin, A, C. Cowan, S. Heffler, et al., “National Health Spending in 2005.” Health Affairs 26: 1(2006): 142–153.
Borger, C., et al., “Health Spending Projections Through 2015: Changes on the Horizon,” Health Affairs Web Exclusive W61: 22 February 2006.
Dr. Cohen and Ms. Krauss, in the March 2003 Health Affairs 22(2), pp. 129–138.
Beyea, SC. and Nicoll, LH. (1999). Finding answers to questions using cost analysis. AORN, 70(1), 128.
Gibbons RJ, Holmes DR, Reeder GS, et al. Immediate angioplasty compared with the administration of a thrombolytic agent followed by conservative treatment for myocardial infarction. The Mayo Coronary Care Unit and Catheterization Laboratory Groups. N Engl J Med. 1993; 328: 685–691.
Le May MR, Davies RF, Labinaz M, et al. Hospitalization costs of primary stenting versus thrombolysis in acute myocardial infarction: cost analysis of the Canadian STAT Study. Circulation 2003; 108: 2624–30.
Cohen DJ, Taira DA, Berezin R, et al. Cost-effectiveness of coronary stenting in acute myocardial infarction: results from the Stent Primary Angioplasty in Myocardial Infarction (StentPAMI) Trial. Circulation. 2001; 104: 3039–3045.
Bakhai A, Stone GW, Murphy SA, et al. Cost-effectiveness of coronary stenting and abciximab for patients with AMI: results from the CADILLAC Trial. Circulation. 2002; 106(suppl II): II-518. Abstract.
Machecourt J, Bonnefoy E, Vanzetto G, et al. Primary angioplasty is cost-minimizing compared with pre-hospital Thrombolysis for patients within 60 min of a percutaneous coronary intervention center: The Comparison of Angioplasty and Pre-hospital thrombolysis in Acute Myocardial Infarction (CAPTIM) cost-efficacy sub-study, JACC. 2005; 45: 515–524.
Weintraub WS et al. “Economic Impact of GPIIB/IIIA Blockade After High-Risk Angioplasty: Results of the Restore Trial” JACC 1999; 34(4): 1061–1066.
Kupersmith, Joel “Cost-Effectiveness Analysis” in Clinical Cardiology Council Newsletter Summer 1995 Cost Effectiveness in Health and Medicine Ed. MR
Gold, JE Siegel, LB Russell, MC Weinstein Oxford University Press NY 1996.
Califf, RM ED. “Economics and Cost-Effectiveness in Evaluating the Value of Cardiovascular Therapies” Am Heart J 1999 137: S35–S144
Mark DB et al. “Baseline and 6-Month Costs of Primary Angioplasty Therapy for Acute Myocardial Infarction: Results from the Primary Angioplasty Registry” JACC 26(3): 1995: 688–695
Grines CL, Browne DF et al. “A comparison of primary angioplasty with thrombolytic therapy for myocardial infarction” NEJM 1993; 328: 673–679
Stone GW et al. “Analysis of the relative costs and effectiveness of primary angioplasty versus tissue-type plasminogen activator; the Primary Angioplasty in Myocardial Infarction (PAMI)” Trial JACC 1997; 29(5): 901–907
Grines CL et al. “Safety and Cost-Effectiveness of Early Discharge after Primary Angioplasty in Low Risk Patients with Acute Myocardial Infarction” JACC 1998: 31(5): 967–972
Personal communication from Daniel B. Mark MD
Lieu, TA et al. Projected Cost-Effectiveness of Primary Angioplasty for Acute Myocardial Infarction JACC (1997) 30ss(7): 1741–1750
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2009 Humana Press, a part of Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Konstance, R.P., Ivanhoe, R.J. (2009). Health Economics of Primary PCI. In: Tcheng, J. (eds) Primary Angioplasty in Acute Myocardial Infarction. Contemporary Cardiology. Humana Press. https://doi.org/10.1007/978-1-60327-497-5_12
Download citation
DOI: https://doi.org/10.1007/978-1-60327-497-5_12
Published:
Publisher Name: Humana Press
Print ISBN: 978-1-60327-496-8
Online ISBN: 978-1-60327-497-5
eBook Packages: MedicineMedicine (R0)